Pricing
Login
Home
Charts
Search
Watchlist
Products

Marksans Pharma Ltd

MARKSANS
₹291.15-2.64%20 Nov 2026
Reports
Pharma Formulations

Marksans Pharma Ltd

MARKSANS
₹291.15
-2.64%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹13,196Cr
Close
Close Price
₹291.15
Industry
Industry
Pharma Formulations
PE
Price To Earnings
23.56
PS
Price To Sales
3.89
Revenue
Revenue
₹3,392Cr
Rev Gr TTM
Revenue Growth TTM
24.20%
PAT Gr TTM
PAT Growth TTM
60.18%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
586560591642682708620720754856841940
Growth YoY
Revenue Growth YoY%
22.115.218.120.816.326.55.012.210.620.835.630.5
Expenses
ExpensesCr
453450462495543582520576594661628726
Operating Profit
Operating ProfitCr
133110128147139127100145161195213214
OPM
OPM%
22.719.621.722.920.417.916.120.121.322.825.322.8
Other Income
Other IncomeCr
517150281562220352518
Interest Expense
Interest ExpenseCr
353333666677
Depreciation
DepreciationCr
222120202123232724242532
PBT
PBTCr
11310012012514311677133151200207194
Tax
TaxCr
302331273825183437514750
PAT
PATCr
83788998105915899114149159144
Growth YoY
PAT Growth YoY%
33.2-6.126.416.626.616.9-34.71.48.264.3173.944.8
NPM
NPM%
14.213.915.115.215.412.89.413.815.117.419.015.3
EPS
EPS₹
1.81.72.02.12.32.01.32.22.53.33.53.1
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
586560591642682708620720754856841940
Growth YoY
Revenue Growth YoY%
22.115.218.120.816.326.55.012.210.620.835.630.5
Expenses
ExpensesCr
453450462495543582520576594661628726
Operating Profit
Operating ProfitCr
133110128147139127100145161195213214
OPM
OPM%
22.719.621.722.920.417.916.120.121.322.825.322.8
Other Income
Other IncomeCr
517150281562220352518
Interest Expense
Interest ExpenseCr
353333666677
Depreciation
DepreciationCr
222120202123232724242532
PBT
PBTCr
11310012012514311677133151200207194
Tax
TaxCr
302331273825183437514750
PAT
PATCr
83788998105915899114149159144
Growth YoY
PAT Growth YoY%
33.2-6.126.416.626.616.9-34.71.48.264.3173.944.8
NPM
NPM%
14.213.915.115.215.412.89.413.815.117.419.015.3
EPS
EPS₹
1.81.72.02.12.32.01.32.22.53.33.53.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
8937679131,0001,1341,3761,4911,8522,1772,6232,9513,392
Growth
Revenue Growth%
12.1-14.119.09.613.421.38.324.217.620.512.524.2
Expenses
ExpensesCr
7577228348689421,0371,2321,5131,7192,0902,3502,608
Operating Profit
Operating ProfitCr
1364578132192340259339459533601783
OPM
OPM%
15.35.88.613.216.924.717.418.321.120.320.423.1
Other Income
Other IncomeCr
978507425950668399
Interest Expense
Interest ExpenseCr
1071010988911122426
Depreciation
DepreciationCr
2830272327364552748399106
PBT
PBTCr
1071550104157302248338424504561751
Tax
TaxCr
244142436646172109121140185
PAT
PATCr
83113680121239187265315383420566
Growth
PAT Growth%
-26.1-86.3215.9124.750.197.5-21.742.018.721.59.860.2
NPM
NPM%
9.31.53.98.010.717.312.514.314.514.614.216.7
EPS
EPS₹
1.90.20.81.92.95.84.56.46.98.49.212.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
8937679131,0001,1341,3761,4911,8522,1772,6232,9513,392
Growth
Revenue Growth%
12.1-14.119.09.613.421.38.324.217.620.512.524.2
Expenses
ExpensesCr
7577228348689421,0371,2321,5131,7192,0902,3502,608
Operating Profit
Operating ProfitCr
1364578132192340259339459533601783
OPM
OPM%
15.35.88.613.216.924.717.418.321.120.320.423.1
Other Income
Other IncomeCr
978507425950668399
Interest Expense
Interest ExpenseCr
1071010988911122426
Depreciation
DepreciationCr
2830272327364552748399106
PBT
PBTCr
1071550104157302248338424504561751
Tax
TaxCr
244142436646172109121140185
PAT
PATCr
83113680121239187265315383420566
Growth
PAT Growth%
-26.1-86.3215.9124.750.197.5-21.742.018.721.59.860.2
NPM
NPM%
9.31.53.98.010.717.312.514.314.514.614.216.7
EPS
EPS₹
1.90.20.81.92.95.84.56.46.98.49.212.4
Sales CAGR
1 Year13%
3 Years17%
5 Years16%
TTM24%
EBITDA CAGR
1 Year13%
3 Years21%
5 Years12%
TTM54%
PAT CAGR
1 Year10%
3 Years17%
5 Years12%
TTM60%
Avg. ROCE
1 Year17%
3 Years18%
5 Years19%
TTM23%
CFO / EBITDA
1 Year76%
3 Years56%
5 Years56%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
414141414141414545454545
Reserves
ReservesCr
4013934305025958461,0681,7002,0202,4222,9783,287
Current Liabilities
Current LiabilitiesCr
259296235233229299356341390477527600
Non Current Liabilities
Non Current LiabilitiesCr
016171825256184205273281392
Total Liabilities
Total LiabilitiesCr
7227527328049031,2291,6402,1902,6813,2403,8614,360
Current Assets
Current AssetsCr
4404844515315949031,2011,6751,8622,2042,7233,012
Non Current Assets
Non Current AssetsCr
2822682822723093264395158181,0361,1381,347
Total Assets
Total AssetsCr
7227527328049031,2291,6402,1902,6813,2403,8614,360
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
414141414141414545454545
Reserves
ReservesCr
4013934305025958461,0681,7002,0202,4222,9783,287
Current Liabilities
Current LiabilitiesCr
259296235233229299356341390477527600
Non Current Liabilities
Non Current LiabilitiesCr
016171825256184205273281392
Total Liabilities
Total LiabilitiesCr
7227527328049031,2291,6402,1902,6813,2403,8614,360
Current Assets
Current AssetsCr
4404844515315949031,2011,6751,8622,2042,7233,012
Non Current Assets
Non Current AssetsCr
2822682822723093264395158181,0361,1381,347
Total Assets
Total AssetsCr
7227527328049031,2291,6402,1902,6813,2403,8614,360

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3114502723317999237230207458
Investing Cash Flow
Investing Cash FlowCr
-123-21-39-13-60-45-84-259-141-49-248
Financing Cash Flow
Financing Cash FlowCr
-58-33-21-114-1580198-69-65-71
Net Cash Flow
Net Cash FlowCr
-150-1015-760118941762193139
Free Cash Flow
Free Cash FlowCr
-101-141114174133531842235329
CFO To PAT
CFO To PAT%
37.2124.1139.934.1193.274.953.189.573.254.0109.1
CFO To EBITDA
CFO To EBITDA%
22.631.463.920.7121.452.638.370.050.238.876.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3114502723317999237230207458
Investing Cash Flow
Investing Cash FlowCr
-123-21-39-13-60-45-84-259-141-49-248
Financing Cash Flow
Financing Cash FlowCr
-58-33-21-114-1580198-69-65-71
Net Cash Flow
Net Cash FlowCr
-150-1015-760118941762193139
Free Cash Flow
Free Cash FlowCr
-101-141114174133531842235329
CFO To PAT
CFO To PAT%
37.2124.1139.934.1193.274.953.189.573.254.0109.1
CFO To EBITDA
CFO To EBITDA%
22.631.463.920.7121.452.638.370.050.238.876.3

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,8911,9301,2951,0175692,0451,8643,1946,86810,0767,12113,196
Price To Earnings
Price To Earnings
24.4214.339.613.34.78.710.112.021.926.517.023.6
Price To Sales
Price To Sales
2.12.51.41.00.51.51.31.73.13.82.43.9
Price To Book
Price To Book
4.34.52.81.90.92.31.71.83.34.12.44.0
EV To EBITDA
EV To EBITDA
14.345.017.58.22.65.56.37.714.018.210.816.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.234.136.843.945.953.149.847.946.649.549.649.6
OPM
OPM%
15.35.88.613.216.924.717.418.321.120.320.423.1
NPM
NPM%
9.31.53.98.010.717.312.514.314.514.614.216.7
ROCE
ROCE%
22.14.010.217.724.933.721.018.618.818.517.423.1
ROE
ROE%
18.72.67.614.819.026.916.815.215.315.513.917.0
ROA
ROA%
11.51.54.910.013.419.411.412.111.811.810.913.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,8911,9301,2951,0175692,0451,8643,1946,86810,0767,12113,196
Price To Earnings
Price To Earnings
24.4214.339.613.34.78.710.112.021.926.517.023.6
Price To Sales
Price To Sales
2.12.51.41.00.51.51.31.73.13.82.43.9
Price To Book
Price To Book
4.34.52.81.90.92.31.71.83.34.12.44.0
EV To EBITDA
EV To EBITDA
14.345.017.58.22.65.56.37.714.018.210.816.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.234.136.843.945.953.149.847.946.649.549.649.6
OPM
OPM%
15.35.88.613.216.924.717.418.321.120.320.423.1
NPM
NPM%
9.31.53.98.010.717.312.514.314.514.614.216.7
ROCE
ROCE%
22.14.010.217.724.933.721.018.618.818.517.423.1
ROE
ROE%
18.72.67.614.819.026.916.815.215.315.513.917.0
ROA
ROA%
11.51.54.910.013.419.411.412.111.811.810.913.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr15,42414,89413,84213,19610,9588,9177,612
Close PriceClose₹2,029.10935.052,263.20291.15696.20967.30269.40
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE22.3856.2966.8623.5629.3014.46
Price To SalesPS6.471.658.883.892.271.71836.51
RevenueRevenueCr2,3839,0121,5593,3924,8265,2139
Revenue Growth TTMRev Gr TTM%16.8%18.3%20.0%24.2%17.5%11.3%55.0%
PAT Growth TTMPAT Gr TTM%17.4%-44.7%18.3%60.2%12.8%54.3%-80.3%
Market CapitalizationMkt CapCr15,42414,89413,84213,19610,9588,9177,612
Close PriceClose₹2,029.10935.052,263.20291.15696.20967.30269.40
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE22.3856.2966.8623.5629.3014.46
Price To SalesPS6.471.658.883.892.271.71836.51
RevenueRevenueCr2,3839,0121,5593,3924,8265,2139
Revenue Growth TTMRev Gr TTM%16.8%18.3%20.0%24.2%17.5%11.3%55.0%
PAT Growth TTMPAT Gr TTM%17.4%-44.7%18.3%60.2%12.8%54.3%-80.3%
Interviews